The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC).

ABSTRACT: Immunotherapy has emerged as a promising new treatment modality for head and neck cancer, offering the potential for targeted and effective cancer management. Squamous cell carcinomas pose significant challenges due to their aggressive nature and limited treatment options. Conventional therapies such as surgery, radiation, and chemotherapy often have limited success rates and can have significant side effects. Immunotherapy harnesses the power of the immune system to recognize and eliminate cancer cells, and thus represents a novel approach with the potential to improve patient outcomes. In the management of head and neck squamous cell carcinoma (HNSCC), important contributions are made by immunotherapies, including adaptive cell therapy (ACT) and immune checkpoint inhibitor therapy. In th

SUBMITTER: Wang CW 

PROVIDER: S-EPMC10930979 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature